These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22332944)

  • 1. Polymer templating of supercooled indomethacin for polymorph selection.
    McKellar SC; Urquhart AJ; Lamprou DA; Florence AJ
    ACS Comb Sci; 2012 Mar; 14(3):155-9. PubMed ID: 22332944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin Polymorph δ Revealed To Be Two Plastically Bendable Crystal Forms by 3D Electron Diffraction: Correcting a 47-Year-Old Misunderstanding.
    Lightowler M; Li S; Ou X; Zou X; Lu M; Xu H
    Angew Chem Int Ed Engl; 2022 Feb; 61(7):e202114985. PubMed ID: 34902212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
    Duong TV; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
    Yoshioka M; Hancock BC; Zografi G
    J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
    Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anisotropic structure and transformation kinetics of vapor-deposited indomethacin glasses.
    Dawson KJ; Zhu L; Yu L; Ediger MD
    J Phys Chem B; 2011 Jan; 115(3):455-63. PubMed ID: 21166431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mechanical stress in crystallization and relaxation behavior of amorphous indomethacin.
    Bhugra C; Shmeis R; Pikal MJ
    J Pharm Sci; 2008 Oct; 97(10):4446-58. PubMed ID: 18228583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration.
    Siddiqui A; Rahman Z; Khan SR; Awotwe-Otoo D; Khan MA
    Int J Pharm; 2014 Oct; 473(1-2):545-51. PubMed ID: 25089509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.
    Hédoux A; Paccou L; Guinet Y; Willart JF; Descamps M
    Eur J Pharm Sci; 2009 Sep; 38(2):156-64. PubMed ID: 19591926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
    Amharar Y; Curtin V; Gallagher KH; Healy AM
    Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.
    Araya-Sibaja AM; Soldi V; Campos CE; Cardoso SG; Cuffini SL
    Drug Dev Ind Pharm; 2015 May; 41(5):851-8. PubMed ID: 24758712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.